Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
31,250
+50 (0.16%)
Aug 8, 2025, 3:30 PM KST
0.16%
Market Cap1.19T
Revenue (ttm)34.88B
Net Income (ttm)385.08M
Shares Out38.26M
EPS (ttm)9.98
PE Ratio3,099.54
Forward PE139.91
Dividendn/a
Ex-Dividend Daten/a
Volume61,158
Average Volume136,724
Open31,000
Previous Close31,200
Day's Range30,750 - 31,600
52-Week Range21,600 - 45,850
Beta1.63
RSI48.21
Earnings DateAug 13, 2025

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 51
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.